\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ was\\ noncontributory\\.\\ \\ thyroid\\ was\\ non\\ tender\\,\\ not\\ enlarged\\,\\ and\\ no\\ nodules\\ were\\ palpated\\.\ \(0\)\
\-\ free\\ t4\\:\\ 3\\.16\\ \\(nl\\ 0\\.71\\-1\\.85\\)\ \(0\)\
\-\ tsh\\:\\ \\<0\\.08\\ \\(nl\\ 0\\.49\\-4\\.67\\)\ \(0\)\
\-\ t3\\:\\ 154\\ \\(nl\\ 59\\-174\\)\ \(0\)\
\-\ thyroglobulin\\ antibody\\:\\ \\<2\\.0\\ \\(nl\\)\ \(0\)\
\-\ thyroid\\ stimulating\\ immunoglobulin\\:92\\ \\ \\ \\(nl\\)\ \(0\)\
\-\ crp\\:\\ 0\\.109\\ \\(nl\\ 0\\-0\\.7\\)\ \(0\)\
\-\ the\\ diagnosis\\ of\\ thyroiditis\\ was\\ made\\ by\\ exclusion\\ of\\ other\\ causes\\.\ \(0\)\
\-\ no\\ treatment\\ was\\ given\\ \\(expectant\\ management\\)\\,\\ and\\ the\\ patient\\ will\\ follow\\ up\\ over\\ the\\ next\\ 1\\-2\\ months\\ with\\ his\\ endocrinologist\\.\ \(0\)\
\-\ heterogeneously\\ decreased\\ uptake\\ of\\ radiotracer\\ throughout\\ both\\ lobes\\ of\\ the\\ thyroid\\.\ \(0\)\
\-\ 4\\ hour\\ radioactive\\ iodine\\ uptake\\ \\(raiu\\)\\:\\ 1\\.1\\%\ \(0\)\
\-\ 24\\ hour\\ raiu\\:\\ 0\\.8\\%\ \(0\)\
\-\ subacute\\ thyroiditis\ \(5\)\
\-\ ddx\\ for\\ markedly\\ decreased\\ tracer\\ uptake\\:\ \(0\)\
\-\ factitious\\/iatrogenic\\ thyroid\\ hormone\\ ingestion\ \(1\)\
\-\ increased\\ iodine\\ pool\\ \\(e\\.g\\.\\ recent\\ contrast\\ media\\ study\\ or\\ exogenous\\ iodine\\)\ \(0\)\
\-\ anti\\-thyroid\\ medicine\ \(1\)\
\-\ acute\\ or\\ subacute\\ thyroiditis\ \(1\)\
\-\ ectopic\\ thyroid\\ tissue\ \(2\)\
\-\ struma\\ ovarii\ \(1\)\
\-\ toxic\\ intrathoracic\\ goiter\ \(1\)\
\-\ 63\\ yo\\ m\\ w\\/\\ pmh\\ significant\\ for\\ mitral\\ valve\\ replacement\\ 3\\ years\\ ago\\ who\\ now\\ complains\\ of\\ 2\\-3\\ month\\ h\\/o\\ 30\\ pound\\ weight\\ loss\\,\\ decreased\\ appetite\\,\\ increased\\ fatigue\\,\\ and\\ occasional\\ light\\ headedness\\.\\ \\ the\\ patient\\ had\\ no\\ h\\/o\\ recent\\ viral\\ illnesses\\.\ \(0\)\
\-\ the\\ patient\\ was\\ very\\ concerned\\ about\\ his\\ symptoms\\,\\ specifically\\ his\\ loss\\ of\\ weight\\.\\ \\ he\\ had\\ already\\ been\\ to\\ an\\ oncologist\\ who\\ \\"ruled\\ out\\"\\ a\\ malignancy\\.\\ \\ there\\ was\\ some\\ discussion\\ with\\ the\\ endocrinologist\\ of\\ initiating\\ steroids\\,\\ but\\ it\\ was\\ decided\\ that\\ the\\ risks\\ outweighed\\ the\\ benefits\\.\\ \\ therefore\\,\\ after\\ educating\\ the\\ patient\\ about\\ the\\ nature\\ and\\ expected\\ timecourse\\ of\\ this\\ self\\-limited\\ illness\\,\\ the\\ clinical\\ team\\ decided\\ on\\ expectant\\ management\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nl\\:\\ 0\\.11068515561034699\ \(0\)\
\-\ thyroid\\:\\ 0\\.060384697326288116\ \(0\)\
\-\ thyroiditis\\:\\ 0\\.05567101261532433\ \(0\)\
\-\ iodine\\:\\ 0\\.05567101261532433\ \(0\)\
\-\ endocrinologist\\:\\ 0\\.05123602801963178\ \(0\)\
\-\ expectant\\:\\ 0\\.04843971692923064\ \(0\)\
\-\ raiu\\:\\ 0\\.040490203067586605\ \(0\)\
\-\ decided\\:\\ 0\\.03832704748927597\ \(0\)\
\-\ uptake\\:\\ 0\\.035120518186491846\ \(0\)\
\-\ hour\\:\\ 0\\.03222333584534459\ \(0\)\
\-\ \\:\\:\\ 0\\.031179994923880416\ \(0\)\
\-\ h\\/o\\:\\ 0\\.030750411015702805\ \(0\)\
\-\ 3\\.16\\:\\ 0\\.030398339392987923\ \(0\)\
\-\ 59\\-174\\:\\ 0\\.030398339392987923\ \(0\)\
\-\ immunoglobulin\\:92\\:\\ 0\\.030398339392987923\ \(0\)\
\-\ 0\\.109\\:\\ 0\\.030398339392987923\ \(0\)\
\-\ 0\\-0\\.7\\:\\ 0\\.030398339392987923\ \(0\)\
\-\ \\-factitious\\/iatrogenic\\:\\ 0\\.030398339392987923\ \(0\)\
\-\ \\-anti\\-thyroid\\:\\ 0\\.030398339392987923\ \(0\)\
\-\ \\-toxic\\:\\ 0\\.030398339392987923\ \(0\)\
\-\ timecourse\\:\\ 0\\.030398339392987923\ \(0\)\
\-\ subacute\\:\\ 0\\.030239321552573684\ \(0\)\
\-\ \\-increased\\:\\ 0\\.028008176701401905\ \(0\)\
\-\ \\-struma\\:\\ 0\\.028008176701401905\ \(0\)\
\-\ headedness\\:\\ 0\\.028008176701401905\ \(0\)\
\-\ educating\\:\\ 0\\.028008176701401905\ \(0\)\
\-\ 154\\:\\ 0\\.026610021156201338\ \(0\)\
\-\ decreased\\:\\ 0\\.026283686924736822\ \(0\)\
\-\ 0\\.49\\-4\\.67\\:\\ 0\\.02561801400981589\ \(0\)\
\-\ \\-ectopic\\:\\ 0\\.02561801400981589\ \(0\)\
\-\ his\\:\\ 0\\.025478162354968262\ \(0\)\
\-\ initiating\\:\\ 0\\.02484855348804275\ \(0\)\
\-\ outweighed\\:\\ 0\\.02484855348804275\ \(0\)\
\-\ ovarii\\:\\ 0\\.02421985846461532\ \(0\)\
\-\ was\\:\\ 0\\.023854974674123473\ \(0\)\
\-\ 0\\.71\\-1\\.85\\:\\ 0\\.023688304396245464\ \(0\)\
\-\ thyroglobulin\\:\\ 0\\.02322785131822987\ \(0\)\
\-\ exogenous\\:\\ 0\\.02322785131822987\ \(0\)\
\-\ self\\-limited\\:\\ 0\\.022821702919414752\ \(0\)\
\-\ \\<\\:\\ 0\\.022745279500012348\ \(0\)\
\-\ about\\:\\ 0\\.02271763797313277\ \(0\)\
\-\ 0\\.08\\:\\ 0\\.022458390796456732\ \(0\)\
\-\ stimulating\\:\\ 0\\.022458390796456732\ \(0\)\
\-\ pound\\:\\ 0\\.022458390796456732\ \(0\)\
\-\ \\(\\:\\ 0\\.022418122538602567\ \(0\)\
\-\ management\\:\\ 0\\.022238147885900974\ \(0\)\
\-\ \\)\\:\\ 0\\.022144273203516366\ \(0\)\
\-\ \\-acute\\:\\ 0\\.022129735004028026\ \(0\)\
\-\ oncologist\\:\\ 0\\.0218296957730293\ \(0\)\
\-\ illnesses\\:\\ 0\\.021553686436224004\ \(0\)\
\-\ weight\\:\\ 0\\.021123764035454243\ \(0\)\
\-\ radioactive\\:\\ 0\\.02062863820658718\ \(0\)\
\-\ intrathoracic\\:\\ 0\\.020245101533793303\ \(0\)\
\-\ recent\\:\\ 0\\.01981185550923998\ \(0\)\
\-\ exclusion\\:\\ 0\\.019739572312442007\ \(0\)\
\-\ 0\\.8\\:\\ 0\\.019739572312442007\ \(0\)\
\-\ concerned\\:\\ 0\\.019739572312442007\ \(0\)\
\-\ antibody\\:\\ 0\\.019586290372542583\ \(0\)\
\-\ 2\\.0\\:\\ 0\\.019439533081443285\ \(0\)\
\-\ benefits\\:\\ 0\\.019439533081443285\ \(0\)\
\-\ tracer\\:\\ 0\\.019298767583097575\ \(0\)\
\-\ t3\\:\\ 0\\.01903338468262817\ \(0\)\
\-\ risks\\:\\ 0\\.01903338468262817\ \(0\)\
\-\ media\\:\\ 0\\.018786974462000082\ \(0\)\
\-\ goiter\\:\\ 0\\.018786974462000082\ \(0\)\
\-\ 1\\.1\\:\\ 0\\.01834141676724144\ \(0\)\
\-\ crp\\:\\ 0\\.018041377536242718\ \(0\)\
\-\ mitral\\:\\ 0\\.018041377536242718\ \(0\)\
\-\ ingestion\\:\\ 0\\.01794689831490439\ \(0\)\
\-\ palpated\\:\\ 0\\.017854938842207284\ \(0\)\
\-\ team\\:\\ 0\\.017678065413284694\ \(0\)\
\-\ already\\:\\ 0\\.01750982346787286\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.017349409620855988\ \(0\)\
\-\ t4\\:\\ 0\\.017271917014469583\ \(0\)\
\-\ pool\\:\\ 0\\.017271917014469583\ \(0\)\
\-\ appetite\\:\\ 0\\.017271917014469583\ \(0\)\
\-\ loss\\:\\ 0\\.01710664946529958\ \(0\)\
\-\ 1\\-2\\:\\ 0\\.01690860489151156\ \(0\)\
\-\ hormone\\:\\ 0\\.01670767762211854\ \(0\)\
\-\ specifically\\:\\ 0\\.016517816321487407\ \(0\)\
\-\ ruled\\:\\ 0\\.016396811770414067\ \(0\)\
\-\ illness\\:\\ 0\\.016396811770414067\ \(0\)\
\-\ 63\\:\\ 0\\.016337865448485443\ \(0\)\
\-\ tsh\\:\\ 0\\.016003900531278828\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.015899399326122526\ \(0\)\
\-\ fatigue\\:\\ 0\\.015748355799714273\ \(0\)\
\-\ e\\.g\\:\\ 0\\.015603651664890025\ \(0\)\
\-\ ddx\\:\\ 0\\.015556735623318373\ \(0\)\
\-\ occasional\\:\\ 0\\.015556735623318373\ \(0\)\
\-\ who\\:\\ 0\\.015365299373391048\ \(0\)\
\-\ w\\/\\:\\ 0\\.015287902721698676\ \(0\)\
\-\ m\\:\\ 0\\.015202755781731879\ \(0\)\
\-\ next\\:\\ 0\\.01495924692926997\ \(0\)\
\-\ viral\\:\\ 0\\.014843651439481546\ \(0\)\
\-\ valve\\:\\ 0\\.014731805661022395\ \(0\)\
\-\ pmh\\:\\ 0\\.014659207698271249\ \(0\)\
\-\ replacement\\:\\ 0\\.01438319836146595\ \(0\)\
\-\ expected\\:\\ 0\\.014350200254513707\ \(0\)\
\-\ noncontributory\\:\\ 0\\.01412765362990139\ \(0\)\
\-\ medicine\\:\\ 0\\.013977049962650834\ \(0\)\
\-\ markedly\\:\\ 0\\.013947702756899424\ \(0\)\
\-\ nature\\:\\ 0\\.013947702756899424\ \(0\)\
\-\ therefore\\:\\ 0\\.01391860320984472\ \(0\)\
\-\ steroids\\:\\ 0\\.013861130615068128\ \(0\)\
\-\ discussion\\:\\ 0\\.013804600236531312\ \(0\)\
\-\ radiotracer\\:\\ 0\\.013748981678152404\ \(0\)\
\-\ light\\:\\ 0\\.013748981678152404\ \(0\)\
\-\ \\%\\:\\ 0\\.013747041609282811\ \(0\)\
\-\ complains\\:\\ 0\\.013694245991406576\ \(0\)\
\-\ pe\\:\\ 0\\.01323718855705491\ \(0\)\
\-\ lobes\\:\\ 0\\.012985042816265384\ \(0\)\
\-\ had\\:\\ 0\\.012716205649935919\ \(0\)\
\-\ nodules\\:\\ 0\\.012215582294492246\ \(0\)\
\-\ non\\:\\ 0\\.012180395500787965\ \(0\)\
\-\ free\\:\\ 0\\.012128279508339522\ \(0\)\
\-\ tender\\:\\ 0\\.011960037562927687\ \(0\)\
\-\ patient\\:\\ 0\\.01181506111608811\ \(0\)\
\-\ made\\:\\ 0\\.011737490938315373\ \(0\)\
\-\ causes\\:\\ 0\\.011470967923482109\ \(0\)\
\-\ 24\\:\\ 0\\.011456748209054998\ \(0\)\
\-\ malignancy\\:\\ 0\\.011386516130350055\ \(0\)\
\-\ 30\\:\\ 0\\.011331342539500258\ \(0\)\
\-\ throughout\\:\\ 0\\.011030163194137677\ \(0\)\
\-\ ago\\:\\ 0\\.010968030416542237\ \(0\)\
\-\ very\\:\\ 0\\.010695812477438376\ \(0\)\
\-\ given\\:\\ 0\\.010101428939711526\ \(0\)\
\-\ now\\:\\ 0\\.010072812378281542\ \(0\)\
\-\ enlarged\\:\\ 0\\.010053865759944849\ \(0\)\
\-\ out\\:\\ 0\\.009738116816753503\ \(0\)\
\-\ study\\:\\ 0\\.00969528054089641\ \(0\)\
\-\ follow\\:\\ 0\\.00936275679981529\ \(0\)\
\-\ \\,\\:\\ 0\\.009334829845423703\ \(0\)\
\-\ will\\:\\ 0\\.009218900063376351\ \(0\)\
\-\ clinical\\:\\ 0\\.00906658551746898\ \(0\)\
\-\ some\\:\\ 0\\.008948028461609515\ \(0\)\
\-\ no\\:\\ 0\\.008901146386591055\ \(0\)\
\-\ yo\\:\\ 0\\.00886672939069918\ \(0\)\
\-\ month\\:\\ 0\\.008840050140691757\ \(0\)\
\-\ years\\:\\ 0\\.008652562541443042\ \(0\)\
\-\ he\\:\\ 0\\.008221335662182826\ \(0\)\
\-\ 4\\:\\ 0\\.00821024794889326\ \(0\)\
\-\ months\\:\\ 0\\.00804807342996575\ \(0\)\
\-\ been\\:\\ 0\\.008016534101599969\ \(0\)\
\-\ up\\:\\ 0\\.007923610865704218\ \(0\)\
\-\ significant\\:\\ 0\\.007923610865704218\ \(0\)\
\-\ both\\:\\ 0\\.007524827554090074\ \(0\)\
\-\ over\\:\\ 0\\.007502215828068836\ \(0\)\
\-\ symptoms\\:\\ 0\\.0073436464720625485\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.007241844957351093\ \(0\)\
\-\ increased\\:\\ 0\\.007208568213102261\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.007102584489593941\ \(0\)\
\-\ tissue\\:\\ 0\\.006984210994664116\ \(0\)\
\-\ or\\:\\ 0\\.006907053441129018\ \(0\)\
\-\ 3\\:\\ 0\\.006899915609332895\ \(0\)\
\-\ other\\:\\ 0\\.0067918570644912015\ \(0\)\
\-\ diagnosis\\:\\ 0\\.006766273554415241\ \(0\)\
\-\ were\\:\\ 0\\.006690642540310073\ \(0\)\
\-\ it\\:\\ 0\\.006623615119079367\ \(0\)\
\-\ contrast\\:\\ 0\\.006595778230372087\ \(0\)\
\-\ but\\:\\ 0\\.006284494141494957\ \(0\)\
\-\ after\\:\\ 0\\.006096555871066216\ \(0\)\
\-\ treatment\\:\\ 0\\.005964196412416851\ \(0\)\
\-\ the\\:\\ 0\\.005720660056701757\ \(0\)\
\-\ that\\:\\ 0\\.005089588719168356\ \(0\)\
\-\ for\\:\\ 0\\.005028332059604932\ \(0\)\
\-\ by\\:\\ 0\\.004906451390499568\ \(0\)\
\-\ there\\:\\ 0\\.004385226056775823\ \(0\)\
\-\ not\\:\\ 0\\.004257995419799777\ \(0\)\
\-\ an\\:\\ 0\\.0040747064285680335\ \(0\)\
\-\ this\\:\\ 0\\.003314266252807355\ \(0\)\
\-\ of\\:\\ 0\\.003213897953047957\ \(0\)\
\-\ on\\:\\ 0\\.0024961759047083727\ \(0\)\
\-\ and\\:\\ 0\\.002482882837685772\ \(0\)\
\-\ to\\:\\ 0\\.0014726486498034008\ \(0\)\
\-\ \\.\\:\\ 0\\.001468946321269501\ \(0\)\
\-\ a\\:\\ 0\\.0013675855235124182\ \(0\)\
\-\ with\\:\\ 0\\.0008069253523440671\ \(0\)\
